GlassScriptPhysician profile
Paul C Diamond
NPI 1427032796
$7,997.02
in general payments reported to CMS, 2019-2025
49 companies · $949 in 2025
The $949 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2020: $1,033 · 2021: $1,292 · 2022: $869 · 2023: $1,558 · 2024: $1,166 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,672.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,133.88 | 2019-2025 | Repatha, Krystexxa, Evenity |
| Abbvie INC. | $767.21 | 2021-2025 | Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $616.39 | 2019-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $590.49 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $560.41 | 2019-2023 | Xarelto, Spravato |
| Amarin Pharma, INC. | $399.07 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $341.83 | 2019-2024 | |
| Astellas Pharma US INC | $323.90 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $282.84 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $258.55 | 2020-2025 | Aveir, Freestyle Libre 2, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $196.70 | 2019-2025 | Airsupra, Wainua |
| Kvk-Tech, INC. | $173.17 | 2020-2024 | |
| Esperion Therapeutics, INC. | $169.34 | 2020-2024 | Nexletol |
| Lilly USA, LLC | $165.73 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $154.63 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Diamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.